Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.
about
A review of current status of living donor liver transplantationManagement of recurrent hepatocellular carcinoma after liver transplantGood longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinomaIndications for living donor liver transplantation in patients with hepatocellular carcinoma.Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital.ZIP4, a novel determinant of tumor invasion in hepatocellular carcinoma, contributes to tumor recurrence after liver transplantation.Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison.Living donor liver transplantation for patients with hepatocellular carcinomaBiological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation.Current management of hepatocellular carcinoma: an Eastern perspective.Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence.Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.Liver transplantation for unresectable colorectal liver metastasis.Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma.
P2860
Q26749857-01D5E0F8-4FF4-4667-9052-BCC530005E25Q26997063-62DAFCDB-22E2-45B1-B8B8-A3E67D9E38C0Q33960740-E2069919-02C2-4321-AC8F-E1437865927AQ34957259-F6660FB9-B5EC-4A8B-97AC-53BBC78BE8F6Q37360166-116E4FC0-EB84-4AD2-8B9C-626225660FD8Q37360183-E806E142-A843-4885-A3B2-AF90190D8BB9Q37642348-8367A5C9-7857-478C-ADFB-F90BEFA606CCQ37708048-B995D99B-2D89-4D43-8944-35DB512DD176Q38221511-B1625B5C-4BC4-4CF4-A907-71DE4D7CA627Q38269467-69AB7958-AA32-41C3-B902-B5E1F0BC7FCBQ38410816-122D152D-DF8C-4EE6-9CC2-77BBFBEE4E99Q38933888-21C89CE3-489B-4C63-9BF1-C61A3526B229Q39223475-D8BB5793-062C-491B-96FB-5F757EFBCD7EQ41955705-1E015054-7A85-450E-93D9-66636891283BQ42364729-5178AFF2-CF0C-4EAC-850D-19D267D4253EQ44590324-F3DF5595-BB5D-4285-9941-55D8F3DFE6F5Q47325009-5A832326-D998-4A40-AAF9-2C9BC84D1C16
P2860
Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.
@en
Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.
@nl
type
label
Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.
@en
Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.
@nl
prefLabel
Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.
@en
Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.
@nl
P2093
P2860
P1476
Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.
@en
P2093
Chung Mau Lo
Kelvin K Ng
See Ching Chan
Sheung Tat Fan
Tan-To Cheung
P2860
P2888
P304
P356
10.1007/S00534-009-0165-8
P577
2009-09-17T00:00:00Z